Dr. A. Michael Lincoff, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk(SIGNIFICANT), Akcea(SIGNIFICANT), Novartis(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Johnson & Johnson(SIGNIFICANT), Novartis(SIGNIFICANT), Edwards Lifesciences(SIGNIFICANT), Medtronic(SIGNIFICANT), Amgen(SIGNIFICANT), CSL Behring(SIGNIFICANT), Janssen(SIGNIFICANT), Lilly(SIGNIFICANT), Pfizer(SIGNIFICANT), Ethicon(SIGNIFICANT), Infraredx(SIGNIFICANT), AbbVie, Inc.(SIGNIFICANT), Astra Zeneca(SIGNIFICANT), Esperion(SIGNIFICANT)

View Full Disclosure